RxDoctor Payments Data

John Clohisy, MD

Adult Reconstructive Orthopaedic Surgery · Saint Louis, MONPI 1972521516

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $483,499 of the $538,064 with a category attached, or 89.9%. Microport Orthopedics Inc accounts for 90.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $104,023 and has fallen 88.0% since, to $12,518 in 2025. Among adult reconstructive orthopaedic surgery clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$538,064in general payments, 2019–2025

Across 113 payments — averaging $4761.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microport Orthopedics Inc$488K
  • Encore Medical, LP$24K
  • Zimmer Biomet$19K
  • Synthes GmbH$3K
  • Alphatec Spine, Inc$1K
  • Medtronic$1K
  • plus $2K from 10 others
$587,974in research payments, 2019–2025

Across 9 payments — averaging $65,330 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$588K

What the payments were for

  • Royalty or licence$483,49990%
  • Consulting fees$44,1408%
  • Speaking & faculty fees$2,0000%
  • Travel & lodging$4,0941%
  • Food & beverage$4,3321%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$538,064 in reported general payments places this provider in the 90th percentile of 36 adult reconstructive orthopaedic surgery providers in Missouri.

See all adult reconstructive orthopaedic surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$168,202
Medicare patients
252
Services billed
591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban20$11,340
Mupirocin158$934
Amoxicillin68$104
Clindamycin Hcl20$82
Meloxicam41$68

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →